Search results for " Modifier"

showing 10 items of 35 documents

Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants

2019

Purpose: To assess the contribution of rare variants in the genetic background toward variability of neurodevelopmental phenotypes in individuals with rare copy-number variants (CNVs) and gene-disruptive variants. Methods: We analyzed quantitative clinical information, exome sequencing, and microarray data from 757 probands and 233 parents and siblings who carry disease-associated variants. Results: The number of rare likely deleterious variants in functionally intolerant genes (“other hits”) correlated with expression of neurodevelopmental phenotypes in probands with 16p12.1 deletion (n=23, p=0.004) and in autism probands carrying gene-disruptive variants (n=184, p=0.03) compared with thei…

MaleParents0301 basic medicineProbandNeuronalGenetic Carrier Screening16p11.2 deletion030105 genetics & heredityCognitionFamily historyNeural Cell Adhesion MoleculesGenetics (clinical)Exome sequencingSequence DeletionGeneticsGenetic Carrier ScreeningPhenotypePenetrancePedigreePhenotypeAutistic Disorder/genetics; Autistic Disorder/physiopathology; Cell Adhesion Molecules Neuronal/genetics; Chromosomes Human Pair 16/genetics; Cognition/physiology; DNA Copy Number Variations/genetics; Female; Gene Expression Regulation/genetics; Genetic Background; Genetic Carrier Screening; Humans; Male; Methyltransferases/genetics; Nerve Tissue Proteins/genetics; Parents; Pedigree; Phenotype; Proteins/genetics; Sequence Deletion/genetics; Siblings; 16p11.2 deletion; CNV; autism; modifier; phenotypic variabilityFemaleGenetic BackgroundHumanDNA Copy Number VariationsCell Adhesion Molecules NeuronalCNVautismNerve Tissue ProteinsBiologyChromosomesArticle03 medical and health sciencesmental disordersmedicineHumansAutistic DisorderBiologyGenemodifierPair 16SiblingsCalcium-Binding ProteinsProteinsMethyltransferasesmedicine.disease16p11.2 deletion; autism; CNV; modifier; phenotypic variability; Genetics (clinical)Cytoskeletal Proteins030104 developmental biologyGene Expression Regulation[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsAutismphenotypic variabilityHuman medicine16p11.2 deletion; autism; CNV; modifier; phenotypic variability; Autistic Disorder; Cell Adhesion Molecules Neuronal; Chromosomes Human Pair 16; Cognition; DNA Copy Number Variations; Female; Gene Expression Regulation; Genetic Background; Humans; Male; Methyltransferases; Nerve Tissue Proteins; Parents; Pedigree; Phenotype; Proteins; Sequence Deletion; Siblings; Genetic Carrier ScreeningCell Adhesion MoleculesChromosomes Human Pair 16Transcription FactorsGenetics in Medicine
researchProduct

Therapy of Peritoneal Murine Cancer with Biological Response Modifiers

1985

We have used a murine renal adenocarcinoma of spontaneous origin (Renca) inplanted in the peritoneal cavity to study the therapeutic potential of biological response modifiers (BRMs) used alone or in conjunction with chemotherapy. This tumor model is therapeutically challenging since following intraperitoneal (i.p.) injection, the tumor grows progressively with hemorrhagic ascites, abdominal metastases to lymph nodes, liver, spleen, most serous membranes, and, in some animals, metastases to extra-abdominal sites (lungs). In the absence of therapy, death invariably occurs within 36 +/- 2 days. The tumor is efficiently lysed in 4 hours by peritoneal cells isolated from mice treated with BRMs.…

MalePathologymedicine.medical_specialtyPolymersPyran Copolymermedicine.medical_treatmentImmunologySpleenAdenocarcinomaToxicologyMicePeritoneal cavitymedicineAnimalsBiological response modifiersPeritoneal NeoplasmsPharmacologyMice Inbred BALB CChemotherapybusiness.industryCancerImmunotherapymedicine.diseaseKidney NeoplasmsKiller Cells NaturalSerous fluidmedicine.anatomical_structureDoxorubicinInterleukin-2FemaleImmunotherapyLymphbusinessJournal of Immunopharmacology
researchProduct

Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients.

2006

Small ubiquitin-related modifier (SUMO4), located in IDDM5, has been identified as a potential susceptibility gene for type 1 diabetes mellitus (T1DM). The novel polymorphism M55V, causing an amino acid change in the evolutionarily conserved met55 residue has been shown to activate the nuclear factor kappaB (NF-kappaB), hence the suspected role of SUMO4 in the pathogenicity of T1DM. The M55V polymorphism has been shown to be associated with susceptibility to T1DM in Asians, but not in Caucasians. Latent autoimmune diabetes in adults (LADA) is a slowly progressive form of T1DM and SUMO4 M55V has not been studied in LADA to date. The current study aims to test whether Latvians are similar to …

Maleendocrine system diseasesAdolescentHuman leukocyte antigenBiologyPolymerase Chain ReactionPolymorphism Single NucleotideGeneral Biochemistry Genetics and Molecular Biologylaw.inventionAutoimmune DiseasesMethionineHistory and Philosophy of ScienceGene Frequencyimmune system diseaseslawmedicineHumansGenetic Predisposition to DiseaseAlleleChildPolymerase chain reactionAllelesGeneticsType 1 diabetesGeneral NeuroscienceInfantmedicine.diseasePathogenicityLatviaDiabetes Mellitus Type 1Autoimmune diabetesCase-Control StudiesChild PreschoolSmall Ubiquitin-Related Modifier ProteinsAmino acid changeFemaleRestriction fragment length polymorphismPolymorphism Restriction Fragment LengthAnnals of the New York Academy of Sciences
researchProduct

Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease.

2014

Mutations in the GDAP1 gene cause different forms of Charcot-Marie-Tooth (CMT) disease, and the primary clinical expression of this disease is markedly variable in the dominant inheritance form (CMT type 2K; CMT2K), in which carriers of the GDAP1 p.R120W mutation can display a wide range of clinical severity. We investigated the JPH1 gene as a genetic modifier of clinical expression variability because junctophilin-1 (JPH1) is a good positional and functional candidate. We demonstrated that the JPH1-GDAP1 cluster forms a paralogon and is conserved in vertebrates. Moreover, both proteins play a role in Ca(2+) homeostasis, and we demonstrated that JPH1 is able to restore the store-operated Ca…

Nerve Tissue ProteinsDiseaseMitochondrionBiologyCell LineEvolution MolecularMiceCharcot-Marie-Tooth DiseaseGeneticsAnimalsHumansGenetic Predisposition to DiseaseStromal Interaction Molecule 1Molecular BiologyGeneGenetics (clinical)PhylogenyGenes ModifierActivator (genetics)Endoplasmic reticulumMembrane ProteinsSTIM1General MedicinePhenotypeMolecular biologyMitochondriaNeoplasm ProteinsMutationCalciumHomeostasisHuman molecular genetics
researchProduct

Effect of heating of organo-montmorillonites under different atmospheres

2009

Abstract We studied the influence of heating on the behaviour of two organo-montmorillonites paying particular attention to the possible degradation effects of the organic modifier under different atmospheres. Hoffmann elimination and anucleophilic substitution on the nitrogen led to rapid degradation of the modifier. As confirmed by deconvoluted FTIR spectra, the presence of oxygen accelerated the degradation rate. The degradation products of the modifier (α-olefins transforming into various carboxyl compounds if oxygen is present) initially increased the basal spacing, followed by a collapse of the particle layers when the decomposition products migrated toward the surface and eventually …

Organic modifierInorganic chemistryOxygenechemistry.chemical_elementGeologyOxygenNitrogenDecompositionSilicatechemistry.chemical_compoundDegradationMontmorillonitechemistryGeochemistry and PetrologyOxidationDegradation (geology)Particlecomputercomputer.programming_languageMontmorillonite
researchProduct

Multi-Alkenylsilsesquioxanes as Comonomers and Active Species Modifiers of Metallocene Catalyst in Copolymerization with Ethylene.

2018

The copolymers of ethylene (E) with open-caged iso-butyl-substituted tri-alkenyl-silsesquioxanes (POSS-6-3 and POSS-10-3) and phenyl-substituted tetra-alkenyl-silsesquioxane (POSS-10-4) were synthesized by copolymerization over the ansa-metallocene catalyst. The influence of the kind of silsesquioxane and of the copolymerization conditions on the reaction performance and on the properties of the copolymers was studied. In the case of copolymerization of E/POSS-6-3, the positive comonomer effect was observed, which was associated with the influence of POSS-6-3 on transformation of the bimetallic ion pair to the active catalytic species. Functionality of silsesquioxanes and polymerization par…

Polymers and Plastics02 engineering and technologyPost-metallocene catalyst010402 general chemistry01 natural sciencesArticlelcsh:QD241-441chemistry.chemical_compoundlcsh:Organic chemistryPolymer chemistryCopolymerethylenecrosslinkingchemistry.chemical_classificationmetalloceneComonomerGeneral ChemistryPolymer021001 nanoscience & nanotechnologySilsesquioxaneethylene; polyhedral oligomeric silsesquioxanes (POSS); copolymerization; metallocene; crosslinking; active site modifier0104 chemical sciencesactive site modifiercopolymerizationchemistryPolymerization0210 nano-technologyGlass transitionMetallocenepolyhedral oligomeric silsesquioxanes (POSS)Polymers
researchProduct

Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity

2009

Heat shock protein 27 (HSP27) accumulates in stressed cells and helps them to survive adverse conditions. We have already shown that HSP27 has a function in the ubiquitination process that is modulated by its oligomerization/phosphorylation status. Here, we show that HSP27 is also involved in protein sumoylation, a ubiquitination-related process. HSP27 increases the number of cell proteins modified by small ubiquitin-like modifier (SUMO)-2/3 but this effect shows some selectivity as it neither affects all proteins nor concerns SUMO-1. Moreover, no such alteration in SUMO-2/3 conjugation is achievable by another HSP, such as HSP70. Heat shock factor 1 (HSF1), a transcription factor responsib…

Protein sumoylationTranscriptional ActivationCancer Researchendocrine systemanimal structuresSUMO proteinHSP27 Heat-Shock ProteinsBiologyurologic and male genital diseasesenvironment and public healthSubstrate Specificity03 medical and health sciencesTransactivation0302 clinical medicineHeat Shock Transcription FactorsHeat shock proteinGeneticsAnimalsHumansAnimals Cell Nucleus/metabolism DNA-Binding Proteins/*metabolism HSP27 Heat-Shock Proteins/chemistry/*metabolism Hela Cells Humans Protein Multimerization Protein Structure[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyHSF1Protein Structure QuaternaryMolecular BiologyTranscription factorUbiquitinsHeat-Shock Proteins030304 developmental biologyCell Nucleus0303 health sciencesMolecular biologyHsp70Cell biologyHeat shock factorDNA-Binding ProteinsProtein TransportQuaternary Protein Transport Small Ubiquitin-Related Modifier Proteins/*metabolism Substrate Specificity Transcription Factors/*metabolism Transcriptional Activation Ubiquitins/*metabolism030220 oncology & carcinogenesisembryonic structuresSmall Ubiquitin-Related Modifier ProteinsProtein MultimerizationHeLa CellsMolecular ChaperonesTranscription Factors
researchProduct

New amphiphilic derivatives of poly(ethylene glycol) as surface modifiers of colloidal drug carriers

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoSURFACE MODIFIERS AMPHIPHILIC COPOLYMERS
researchProduct

Thermo-oxidative ageing of an organo-modified clay and effects on the properties of PA6 based nanocomposites

2013

a b s t r a c t In this work a careful investigation on the degradation of an organically modified montmorillonite sample (Cloisite 15A) thermal treated under different atmospheres, namely nitrogen, air and oxygen enriched atmosphere was performed. The exposure time of the thermal treatment ranged between 5 and 300 min. The chemical composition evolution as function of the thermal treatment conditions of the clay organic modifier was monitored by means of combined thermogravimetry/Fourier transform infrared spectroscopy (TGA-FTIR). Moreover, the morphological behaviour of treated Cloisite 15A sam- ples as function of the time and of the decomposition atmosphere was investigated by X-ray dif…

Thermogravimetric analysisMaterials scienceNanocompositeMontmorillonite Organic modifier Degradation Nanocomposites TGA–FTIRThermal treatmentCondensed Matter PhysicsThermogravimetrychemistry.chemical_compoundMontmorillonitechemistryLimiting oxygen concentrationPhysical and Theoretical ChemistryFourier transform infrared spectroscopyComposite materialThermal analysisInstrumentation
researchProduct

New amphiphilic conjugates of mono- and bis(carboxy)-PEG(2,000) polymers with lipoamino acids as surface modifiers of colloidal drug carriers

2010

chemistry.chemical_classificationamphiphilesPolymers and Plasticspoly(ethylene glycol)Organic Chemistrylipoaminoacids copolymers surface modifiers drug carrierslipoamino acidslong-circulating drug-delivery systemsPolymerCondensed Matter PhysicsColloidMatrix-assisted laser desorption/ionizationchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPolymer chemistryAmphiphileamphiphiles; conjugated polymers; lipoamino acids; long-circulating drug-delivery systems; MALDI-TOF MS; poly(ethylene glycol)Materials Chemistryconjugated polymersMALDI-TOF MSPhysical and Theoretical ChemistryDrug carrierConjugate
researchProduct